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© 2010 The Japan Society of Histochemistry and Cy- We have recently reported that salivary gland cells express the lymphatic endothelial
cell marker podoplanin. The present study was aimed to immunohistochemically investigate
the expression of the myoepithelial cell marker α-smooth muscle actin (SMA) on podoplanin-
positive cells in mouse parotid and sublingual glands, and to elucidate podoplanin
localization in salivary gland myoepithelial cells by immunoelectron microscopic study. The
distribution of myoepithelial cells expressing podoplanin and α-SMA was examined by
immunofluorescent staining, and the localization of reaction products of anti-podoplanin
antibody was investigated by pre-embedded immunoelectron microscopic method. In
immunohistochemistry, the surfaces of both the mucous acini terminal portion and ducts
were covered by a number of extensive myoepithelial cellular processes expressing
podoplanin, and the immunostaining level with anti-podoplanin antibody to myoepithelial
cells completely coincided with the immunostaining level with anti-α-SMA antibody. These
findings suggest that podoplanin is a salivary gland myoepithelial cell antigen, and that
the detection level directly reflects the myoepithelial cell distribution. In immunoelectron
microscopic study, a number of reaction products with anti-podoplanin antibody were
found at the Golgi apparatus binding to the endoplasmic reticulum in the cytoplasm of
myoepithelial cells between sublingual gland acinar cells, and were also found at the
myoepithelial cell membrane. These findings suggest that salivary gland myoepithelial cells
constantly produce podoplanin and glycosylate at the Golgi apparatus, and transport
them to the cell membrane. Podoplanin may be involved in maintaining the homeostasis of
myoepithelial cells through its characteristic as a mucin-type transmembrane glycoprotein.
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I. Introduction
Lymphatic endothelial cell marker podoplanin was first
identified as a 43-kd transmembrane protein of the kidney
glomerular epithelial cells, the podocytes, and is homolo-
gous to the T1α-2 gene which encodes the type I alveolar
cell specific antigen and to the oncofetal antigen M2A
recognized by the D2-40 antibody [3, 4, 12, 20, 25, 26].
Podoplanin is first expressed at around E11.0 in Prox1-
positive lymphatic progenitor cells [5, 9, 22]. Podoplanin
(−/−) mice die at birth because of respiratory failure and
have defects in lymphatic formation with diminished lym-
phatic transport and congenital lymphedema, but do not
have defects in blood vessel pattern formation [28]. Podo-
planin is a mucin-type glycoprotein negatively charged by
extensive O-glycosylation and a high content of sialic acid
[7, 10, 29–31]. The role of podoplanin has been studied
in a rat model of nephropathy by puromycin aminonucleo-
side nephrosis with severe proteinuria. In the kidney with
nephropathy, podocyte foot processes are extensive flat-Hata et al. 78
tened and podoplanin is selectively reduced to <30%. It
has been thought that podoplanin plays a role in maintaining
the shape of podocyte foot processes and glomerular per-
meability because of the morphological alterations of cell
shape with selective loss of podoplanin in nephrosis accom-
panies proteinuria [3, 11, 16, 17].
There have also been reports on podoplanin expression
in osteocytes and osteoblasts [32], odontoblasts and enamel
epithelia [27], mesothelial cells [19], epidermal basal layer
cells [12], choroid plexus epithelial cells [34], thymus type
I epithelial cells [3], prostate myofibroblasts [20, 24], fol-
licular dendritic cells [14, 35], and immature cells like fetal
germ cells and developing Sertoli cells [10, 29, 37]. Elucida-
tion of the biological importance of these somatic tissues is
required. We were initially interested in examining the lym-
phatic distribution in major salivary grands by immuno-
staining for a lymphatic endothelial cell marker, podoplanin.
By chance, we discovered that most podoplanin-positive
cells in major salivary glands were myoepithelial cells rather
than lymphatic endothelial cells [8]. Podoplanin expression
is rarely found in the acini of the parotid gland but clearly
found at the basal portion surrounding acinar cells in sub-
mandibular and sublingual glands. Strong expression of
podoplanin is also found at the basal portion of the inter-
calated duct, striated duct, and interlobular duct in all major
salivary glands [8]. The terminal portion of the parotid gland
is covered by only a few myoepithelial cells whereas the
terminal portions of sublingual and submandibular gland,
and also the ducts are covered by a number of broad and
extensive cellular processes [18]. Podoplanin could be a
marker protein of salivary gland myoepithelial cells because
podoplanin detection levels coincide with the distribution
of myoepithelial cells specific for major salivary glands. In
a previous study, podoplanin-positive cells were examined
in connection with the reaction with the antibody to the
mammary gland myoepithelial marker P-cadherin [8]. The
elucidation of podoplanin localization on the myoepithelium
requires a transmission immunoelectron microscopic study.
However, the expression of podoplanin in salivary glands
has not been examined at the electron microscopic level.
This study was aimed to investigate the immunoreaction of
podoplanin-positive cells with α-smooth muscle actin (SMA)
used as a marker for myoepithelial cells, and to elucidate
podoplanin localization in salivary gland myoepithelial cells
by the immunoelectron microscopic study.
II. Materials and Methods
Immunostaining for fluorescence microscopy
The salivary gland tissue of 8-week-old closed colony
ICR mice (male, n=5; Charles River Japan Inc., Yokohama,
Japan) was used. Tissue was obtained after euthanasia by
intraperitoneal injection with sodium pentobarbital (10
ml/kg, Nembutal, Abbott Laboratories, North Chicago, IL,
USA). The protocol for animal use was reviewed and ap-
proved by the animal experiment committee of Fukuoka
Dental College, Fukuoka, Japan. We initially used glutaral-
dehyde and formaldehyde to fix tissue, but when the tissue
was treated by the solution this extremely reduced the
immunoreactivity of an antibody for podoplanin. There-
fore, the present study used frozen 8 μm sections which
were cut in a cryostat and fixed in 100% methanol for 2
min at −20°C for the immunofluorescent staining and the
pre-embedding immunoelectron microscopic examination.
After treatment with 0.1% goat serum (GS) diluted with 10
mM phosphate-buffered saline (PBS, pH 7.4) for 10 min
at room temperature (RT), sections were treated with a
cocktail of primary antibodies: 1 μg/ml of monoclonal ham-
ster anti-mouse podoplanin (anti-podoplanin; AngioBio Co.,
Del Mar, CA) and monoclonal rabbit anti-α-smooth muscle
actin (anti-α-SMA; Epitomics, Inc., Burlingame, CA) for
8 hr at 4°C. Sections were reacted with a cocktail of second
antibodies: 1 μg/ml of AlexaFluor 488-conjugated goat
anti-hamster IgG and AlexaFluor 568-conjugated goat anti-
rabbit IgG (Molecular Probes, Invitrogen, Eugene, OR) in
GS-PBS for 1 hr at RT, and then examined by a fluorescence
microscopy BZ-8100 (Keyence Corp., Osaka, Japan).
Furthermore, the tissue was trimmed on small pieces
of the 5 mm width, fixed in 100% methanol for 10 min at
−20°C, treated with GS-PBS for 3 hr at RT, and then directly
immersed in a cocktail of first antibodies: 1 μg/ml of anti-
podoplanin and anti-α-SMA for 8 hr at 4°C. Next, the tissue
was exposed to a cocktail of second antibodies: 1 μg/ml
of AlexaFluor 488-conjugated goat anti-hamster IgG and
AlexaFluor 568-conjugated goat anti-rabbit IgG in GS-PBS
for 2 hr at RT. The trimmed tissue was also exposed to 1
μg/ml of anti-podoplanin and treated with a cocktail of 1
μg/ml of AlexaFluor 488-conjugated goat anti-hamster IgG
and rhodamine-conjugated concanavalin A (Con A; Molec-
ular Probes) in PBS to visualize the cell membrane. The
immunostained tissues were examined by laser-scanning
confocal microscopy (Axiovert 135M, Carl Zeiss, Jena,
Germany) with a ×40 oil Plan-Apochromatic oil immersion
objective lens (numerical aperture ×1.3).
Immunostaining for electron microscopy
The present study used pre-embedding immuno-
electron microscopy. The tissue was trimmed to small pieces
of 5 mm width. Frozen 40 μm sections were cut in a cryostat
and fixed in 100% methanol for 10 min at −20°C. After
treatment with GS-PBS, sections were treated with anti-
podoplanin (10 μg/ml; AngioBio Co., Del Mar, CA) for 8
hr at 4°C. Next, sections were reacted with a 5 μg/ml of
rabbit anti-goat IgG (Vector-ABC kit; Vector Laboratories,
Inc., Burlingame, CA) for 2 hr at RT and with DAB sub-
strate kit (Vector) for 1 hr at RT, and were post-fixed by
a 4% paraformaldehyde-PBS for 8 hr at RT. Sections were
sequentially fixed in 1% osmium tetroxide-PBS for 30 min
at RT, dehydrated in an ascending ethanol series, and em-
bedded in a resin mixture (Epon 812, 4.8 g; DDSA EM
grade, 1.9 g; MNA EM grade, 3.3 g; DMP-30, 2 g). Ultrathin
sections were prepared with a ultramicrotome (Reichert-
Nissei Ultracuts; Leica Microsystems GmbH, Wetzlar,
Germany) with a diamond knife, exposed to 5% uranyl ace-Podoplanin Localization on Salivary Gland Myoepithelium 79
tate in 50% ethanol for 15 min at RT, washed by deionized
water (DW), exposed to 0.4% lead citrate and 0.4% sodium
hydroxide in DW for 5 min at RT, and examined under a
transmission electron microscope (JEM-1400, JEOL Ltd.,
Tokyo, Japan).
III. Results and Discussion
Immunohistochemistry for the expression of podoplanin and 
α-SMA in salivary glands
Myoepithelial cells exist around acinar cells and at the
basal side of ducts in salivary glands [18]. Myoepithelial cell
shape varies considerably with different glands in relation
to the physical properties of secretions. In the parotid gland,
few myoepithelial cells are present on serous acini except
for ducts while in the sublingual gland, approximately 50%
of the terminal portion surfaces of mucous acini are covered
by a number of broad and extensive myoepithelial cell pro-
cesses [18]. Therefore, in the present study, the congruity of
the podoplanin-positive region to the region where the well-
established myoepithelial cell marker α-SMA is positive
was investigated by whole staining because myoepithelial
cells exist on the surface of acini and ducts [1, 2, 6, 13,
21]. Furthermore, the cross reaction of anti-podoplanin was
investigated by tissue section because no myoepithelial cells
exist in the center of acini and the luminal side of ducts
[18]. As for the whole staining of the sublingual glands,
the surfaces of the whole terminal portion of mucous acini
were stained by a universal cell membrane marker, Con A.
Terminal portion surfaces were also covered by a number of
extensive myoepithelial cellular processes and the immuno-
staining level by anti-podoplanin to myoepithelial cells on
terminal portion surfaces completely coincided with the
immunostaining by anti-α-SMA (Fig. 1). These findings sug-
gest that podoplanin is an antigen for salivary gland myo-
epithelial cells, and that the immunostaining of podoplanin
in the salivary glands directly reflects myoepithelial cell
shapes. For the immunostaining of salivary gland tissue sec-
tions, the region around the acinar cells was immunostained
by both anti-podoplanin and anti-α-SMA. In the sublingual
mucous acini there was more region immunostained with
anti-podoplanin in the sublingual gland mucous acini than in
the parotid gland serous acini. The basal side of the ducts
was also stained with anti-podoplanin in both the parotid and
sublingual glands at the same levels (Fig. 2). These findings
suggest that the detection levels of podoplanin in the sali-
vary glands reflect the distribution of myoepithelial cells.
The basal side of the ducts was stained with anti-podoplanin
Fig. 1. Whole staining of sublingual gland with anti-podoplanin and anti-α-SMA. Concanavalin A (Con A) was used to visualize the cell
membrane of the acinar terminal portion in red. Terminal portion surfaces of mucous acini are covered by a number of extensive myoepithelial
cellular processes with green fluorescence immunostaining by anti-podoplanin of which the degree and extent completely coincide with anti-α-
SMA immunostaining. Bar=100 μm.Hata et al. 80
Fig. 2. Comparison of immunostaining by anti-podoplanin and anti-α-SMA between parotid and sublingual glands. In mouse parotid glands
the terminal secretory end pieces of acini were densely composed of serous pyramidal cells with basophilic cytoplasm. In sublingual gland the
terminal secretory end pieces of acini were composed of large mucus-filled cells with cytoplasm which was less basophilic than that of the
parotid glands. The portion around the acinar cells is immunostained by both anti-podoplanin and anti-α-SMA (merged, in yellow). In the
sublingual gland mucous acini there are more parts that are immunostained with anti-podoplanin in the sublingual gland mucous acini than in
the parotid gland serous acini. The basal side of the ducts is also immunostained with anti-podoplanin in both the parotid and sublingual glands
at the same level, and to a stronger extent than with anti-α-SMA (arrowheads, intercalated duct). There are more parts that are immunostained
with anti-α-SMA than with anti-podoplanin. Reaction products with anti-α-SMA are also found in the center of the acinar and at the luminal
side of the duct where reaction products with anti-podoplanin are not found. Bar=100 μm.
Fig. 3. Immunoelectron microscopy for podoplanin production in the cytoplasm of salivary gland myoepithelial cells. (A) A strong density
of immunostaining with anti-podoplanin is found in the region of the cell membrane and in the cytoplasm of myoepithelial cells between
sublingual gland acinar cells. Some reaction products of anti-podoplanin are also observed at the basal side in the cytoplasm of the acinar cells.
Bar=10 μm. (B) In the higher magnification of the cell highlighted in A (box), a number of reaction products with anti-podoplanin are found
at the Golgi apparatus binding to endoplasmic reticulum (arrowheads). Bar=2 μm.Podoplanin Localization on Salivary Gland Myoepithelium 81
to a stronger extent than with anti-α-SMA in both parotid
and sublingual glands (Fig. 2), suggesting that salivary
gland myoepithelial cells may be more abundant in podopla-
nin than in α-SMA. On the other hand, the center of acini
and luminal side of ducts were immunostained with anti-α-
SMA but not by anti-podoplanin (Fig. 2). Since these are
regions without salivary gland myoepithelial cells [18], it
was conjectured that anti-α-SMA caused cross reaction to
the actin present in cells universally.
Immunoelectron microscopy for the expression of podoplanin 
in salivary gland myoepithelial cells
A number of reaction products with anti-podoplanin
were found at the Golgi apparatus binding to endoplasmic
reticulum in the cytoplasm of myoepithelial cells between
sublingual gland acinar cells (Fig. 3). Furthermore, a number
of reaction products with the anti-podoplanin were localized
at the myoepithelial cell membrane between acinar cells
(Fig. 4). The Golgi apparatus is composed of membrane-
bound cisternae which have networks to the endoplasmic
reticulum, and primarily functions to process proteins, pack-
age the macromolecules, and enable them to make their
way to their destination [23]. The Golgi apparatus plays
a role in the attachment of polysaccharides to a protein
synthesized in the endoplasmic reticulum to form proteo-
glycans. Podoplanin is a mucin-type transmembrane glyco-
protein negatively charged by extensive O-glycosylation
and has a high content of sialic acid. Therefore, it is thought
that podoplanin is continuously produced, glycosylated
with polysaccharides in the Golgi apparatus, and transported
to the cell membrane. Some reaction products with anti-
podoplanin were observed at the basal side near the nuclei in
the cytoplasm of the acinar cells in spite of the absence of
reaction products with anti-podoplanin in the salivary gland
acinar cells by fluorescence microscopy. Further studies on
podoplanin localization in acinar cells by immunoelectron
microscopy are required. It has been reported that podopla-
nin promotes plasma membrane extension and actin cyto-
skeleton rearrangement [15, 30, 33, 36], and that podoplanin
is resistant to proteases because it is a negatively charged
mucin-type protein [3]. Podoplanin may play a role in
maintaining the shape of myoepithelial cell foot processes
to protect acinar cells from the outside.
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